These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21320544)

  • 1. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.
    Sun W; Six D; Kuang X; Roland KL; Raetz CR; Curtiss R
    Vaccine; 2011 Apr; 29(16):2986-98. PubMed ID: 21320544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.
    Sun W; Roland KL; Kuang X; Branger CG; Curtiss R
    Infect Immun; 2010 Mar; 78(3):1304-13. PubMed ID: 20086087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity of Yersinia pestis synthesis of 1-dephosphorylated lipid A.
    Sun W; Six DA; Reynolds CM; Chung HS; Raetz CR; Curtiss R
    Infect Immun; 2013 Apr; 81(4):1172-85. PubMed ID: 23357387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.
    Szaba FM; Kummer LW; Wilhelm LB; Lin JS; Parent MA; Montminy-Paquette SW; Lien E; Johnson LL; Smiley ST
    Infect Immun; 2009 Oct; 77(10):4295-304. PubMed ID: 19620344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.
    Oyston PC; Mellado-Sanchez G; Pasetti MF; Nataro JP; Titball RW; Atkins HS
    Microb Pathog; 2010 May; 48(5):191-5. PubMed ID: 20096773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
    Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK
    mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.
    Sun W; Sanapala S; Henderson JC; Sam S; Olinzock J; Trent MS; Curtiss R
    Infect Immun; 2014 Oct; 82(10):4390-404. PubMed ID: 25114109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yersinia pestis evades TLR4-dependent induction of IL-12(p40)2 by dendritic cells and subsequent cell migration.
    Robinson RT; Khader SA; Locksley RM; Lien E; Smiley ST; Cooper AM
    J Immunol; 2008 Oct; 181(8):5560-7. PubMed ID: 18832714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
    Lin JS; Kummer LW; Szaba FM; Smiley ST
    J Immunol; 2011 Feb; 186(3):1675-84. PubMed ID: 21172869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection.
    Okan NA; Mena P; Benach JL; Bliska JB; Karzai AW
    Infect Immun; 2010 Mar; 78(3):1284-93. PubMed ID: 20065026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.
    Tiner BL; Sha J; Ponnusamy D; Baze WB; Fitts EC; Popov VL; van Lier CJ; Erova TE; Chopra AK
    Clin Vaccine Immunol; 2015 Dec; 22(12):1255-68. PubMed ID: 26446423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.
    Branger CG; Sun W; Torres-Escobar A; Perry R; Roland KL; Fetherston J; Curtiss R
    Vaccine; 2010 Dec; 29(2):274-82. PubMed ID: 20979987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice.
    Anisimov AP; Shaikhutdinova RZ; Pan'kina LN; Feodorova VA; Savostina EP; Bystrova OV; Lindner B; Mokrievich AN; Bakhteeva IV; Titareva GM; Dentovskaya SV; Kocharova NA; Senchenkova SN; Holst O; Devdariani ZL; Popov YA; Pier GB; Knirel YA
    J Med Microbiol; 2007 Apr; 56(Pt 4):443-453. PubMed ID: 17374882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
    Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yersinia pestis YadC: a novel vaccine candidate against plague.
    Murphy BS; Wulff CR; Garvy BA; Straley SC
    Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.
    Zhang Q; Wang Q; Tian G; Qi Z; Zhang X; Wu X; Qiu Y; Bi Y; Yang X; Xin Y; He J; Zhou J; Zeng L; Yang R; Wang X
    Hum Vaccin Immunother; 2014; 10(2):368-77. PubMed ID: 24225642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of New Virulence Factors and Vaccine Candidates for
    Andersson JA; Sha J; Erova TE; Fitts EC; Ponnusamy D; Kozlova EV; Kirtley ML; Chopra AK
    Front Cell Infect Microbiol; 2017; 7():448. PubMed ID: 29090192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.